These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 14769595)

  • 1. Aqueous humor flow in normal human eyes treated with brimonidine and dorzolamide, alone and in combination.
    Tsukamoto H; Larsson LI
    Arch Ophthalmol; 2004 Feb; 122(2):190-3. PubMed ID: 14769595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aqueous humor flow in normal human eyes treated with brimonidine and timolol, alone and in combination.
    Larsson LI
    Arch Ophthalmol; 2001 Apr; 119(4):492-5. PubMed ID: 11296014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of dorzolamide on aqueous humor dynamics in normal human subjects during sleep.
    Vanlandingham BD; Maus TL; Brubaker RF
    Ophthalmology; 1998 Aug; 105(8):1537-40. PubMed ID: 9709770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the early effects of brimonidine and apraclonidine as topical ocular hypotensive agents.
    Maus TL; Nau C; Brubaker RF
    Arch Ophthalmol; 1999 May; 117(5):586-91. PubMed ID: 10326954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of brinzolamide and dorzolamide on aqueous humor flow in human eyes.
    Ingram CJ; Brubaker RF
    Am J Ophthalmol; 1999 Sep; 128(3):292-6. PubMed ID: 10511022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of latanoprost, brimonidine, and a fixed combination of timolol and dorzolamide on circadian intraocular pressure in patients with glaucoma or ocular hypertension.
    Orzalesi N; Rossetti L; Bottoli A; Fumagalli E; Fogagnolo P
    Arch Ophthalmol; 2003 Apr; 121(4):453-7. PubMed ID: 12695241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the ocular hypotensive effect of brimonidine, dorzolamide, latanoprost, or artificial tears added to timolol in glaucomatous monkey eyes.
    Wang RF; Serle JB; Gagliuso DJ; Podos SM
    J Glaucoma; 2000 Dec; 9(6):458-62. PubMed ID: 11131752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aqueous humor flow in human eyes treated with dorzolamide and different doses of acetazolamide.
    Larsson LI; Alm A
    Arch Ophthalmol; 1998 Jan; 116(1):19-24. PubMed ID: 9445204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects on aqueous flow of dorzolamide combined with either timolol or acetazolamide.
    Toris CB; Zhan GL; Yablonski ME; Camras CB
    J Glaucoma; 2004 Jun; 13(3):210-5. PubMed ID: 15118464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of dorzolamide and timolol as suppressors of aqueous humor flow in humans.
    Wayman L; Larsson LI; Maus T; Alm A; Brubaker R
    Arch Ophthalmol; 1997 Nov; 115(11):1368-71. PubMed ID: 9366665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination of systemic acetazolamide and topical dorzolamide in reducing intraocular pressure and aqueous humor formation.
    Rosenberg LF; Krupin T; Tang LQ; Hong PH; Ruderman JM
    Ophthalmology; 1998 Jan; 105(1):88-92; discussion 92-3. PubMed ID: 9442783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of dorzolamide and acetazolamide as suppressors of aqueous humor flow in humans.
    Maus TL; Larsson LI; McLaren JW; Brubaker RF
    Arch Ophthalmol; 1997 Jan; 115(1):45-9. PubMed ID: 9006424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of brimonidine on aqueous humor dynamics in human eyes.
    Toris CB; Gleason ML; Camras CB; Yablonski ME
    Arch Ophthalmol; 1995 Dec; 113(12):1514-7. PubMed ID: 7487618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brimonidine purite 0.15% versus dorzolamide 2% each given twice daily to reduce intraocular pressure in subjects with open angle glaucoma or ocular hypertension.
    Sharpe ED; Day DG; Beischel CJ; Rhodes JS; Stewart JA; Stewart WC
    Br J Ophthalmol; 2004 Jul; 88(7):953-6. PubMed ID: 15205246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dorzolamide/timolol combination versus concomitant administration of brimonidine and timolol: six-month comparison of efficacy and tolerability.
    Sall KN; Greff LJ; Johnson-Pratt LR; DeLucca PT; Polis AB; Kolodny AH; Fletcher CA; Cassel DA; Boyle DR; Skobieranda F
    Ophthalmology; 2003 Mar; 110(3):615-24. PubMed ID: 12623832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in intraocular pressure associated with topical dorzolamide and oral methazolamide in glaucomatous dogs.
    Gelatt KN; MacKay EO
    Vet Ophthalmol; 2001 Mar; 4(1):61-7. PubMed ID: 11397321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of brimonidine, dorzolamide and latanoprost as adjunctive therapy in primary open angle glaucoma.
    Sodhi PK; Pandey RM; Ratan SK
    Int J Clin Pract; 2003 Dec; 57(10):875-8. PubMed ID: 14712889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative acute effects of brimonidine 0.2% versus dorzolamide 2% combined with beta-blockers in glaucoma.
    Centofanti M; Manni G; Gregori D; Cocco F; Lorenzano D; Bucci MG
    Graefes Arch Clin Exp Ophthalmol; 2000 Apr; 238(4):302-5. PubMed ID: 10853928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Efficiency of brimonidine 0.2% and dorzolamide 2% as adjunctive therapy to beta-blockers].
    Carrasco Font C; Arias Puente A; García Sáenz MC; Villarejo Díaz-Maroto I
    Arch Soc Esp Oftalmol; 2004 Apr; 79(4):163-8. PubMed ID: 15124072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of dorzolamide on corneal endothelial function in normal human eyes.
    Egan CA; Hodge DO; McLaren JW; Bourne WM
    Invest Ophthalmol Vis Sci; 1998 Jan; 39(1):23-9. PubMed ID: 9430541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.